Last updated: 2026-09-08 06:14:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Milestone Pharmaceuticals Inc. (MIST) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.21, with a market capitalization of $149.40M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.00 to $3.06. This page covers its latest market performance, valuation, price trends and company information.
$149.40M | |
$1.21 | |
$27.95 | |
$0.63 | |
$1.21 | |
1.42M | |
1.43M | |
-- | |
$3.06 | |
$1.00 | |
-- | |
-- |
Milestone Pharmaceuticals Inc. (MIST) last closed at $1.21 as of 2026-09-04 23:53:00, unchanged from the previous close of $1.21.
During the latest regular trading session, MIST traded between $0.63 and $27.95, with a volume of 1.42M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Milestone Pharmaceuticals Inc. (MIST) moved from $1.19 to $1.21, representing a gain of 1.26% ($0.02).
The stock traded between $1.12 and $1.26 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 1.26 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 10.0%
MIST is currently trading at $1.21, placing it 10.0% of the way from its 52-week low of $1.00 to its 52-week high of $3.06. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 38 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Milestone Pharmaceuticals Inc. (MIST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.